ReShape Lifesciences Inc. (RSLS)
USD 0.49
(29.26%)
USD 0.49
(29.26%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 8.67 Million USD | -22.79% |
| 2022 | 11.24 Million USD | -17.35% |
| 2021 | 13.6 Million USD | 20.36% |
| 2020 | 11.29 Million USD | -25.12% |
| 2019 | 15.08 Million USD | 2387.02% |
| 2018 | 606.71 Thousand USD | -52.86% |
| 2017 | 1.28 Million USD | 63.62% |
| 2016 | 786.66 Thousand USD | 169.4% |
| 2015 | 292 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 312 Thousand USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 1.94 Million USD | -1.92% |
| 2024 Q2 | 1.96 Million USD | 1.08% |
| 2023 Q3 | 2.15 Million USD | -4.39% |
| 2023 Q2 | 2.25 Million USD | -1.44% |
| 2023 Q1 | 2.28 Million USD | -26.46% |
| 2023 FY | 8.67 Million USD | -22.79% |
| 2023 Q4 | 1.98 Million USD | -8.03% |
| 2022 Q1 | 2.44 Million USD | -22.34% |
| 2022 Q2 | 2.89 Million USD | 18.52% |
| 2022 FY | 11.24 Million USD | -17.35% |
| 2022 Q4 | 3.11 Million USD | 11.15% |
| 2022 Q3 | 2.79 Million USD | -3.25% |
| 2021 Q2 | 3.52 Million USD | 9.56% |
| 2021 Q1 | 3.22 Million USD | 0.47% |
| 2021 Q3 | 3.7 Million USD | 5.07% |
| 2021 Q4 | 3.14 Million USD | -15.26% |
| 2021 FY | 13.6 Million USD | 20.36% |
| 2020 Q1 | 2.78 Million USD | -31.14% |
| 2020 FY | 11.29 Million USD | -25.12% |
| 2020 Q3 | 3.6 Million USD | 111.63% |
| 2020 Q4 | 3.2 Million USD | -10.99% |
| 2020 Q2 | 1.7 Million USD | -38.97% |
| 2019 Q3 | 3.51 Million USD | -21.01% |
| 2019 Q2 | 4.45 Million USD | 44.76% |
| 2019 FY | 15.08 Million USD | 2387.02% |
| 2019 Q4 | 4.05 Million USD | 15.22% |
| 2019 Q1 | 3.07 Million USD | 328.23% |
| 2018 Q3 | 350.23 Thousand USD | -46.4% |
| 2018 FY | 606.71 Thousand USD | -52.86% |
| 2018 Q1 | 949.99 Thousand USD | 19.64% |
| 2018 Q2 | 653.36 Thousand USD | -31.22% |
| 2018 Q4 | -1.34 Million USD | -484.57% |
| 2017 Q1 | 40.04 Thousand USD | -71.78% |
| 2017 Q3 | 360.02 Thousand USD | 286.87% |
| 2017 Q2 | 93.06 Thousand USD | 132.42% |
| 2017 Q4 | 794.03 Thousand USD | 120.55% |
| 2017 FY | 1.28 Million USD | 63.62% |
| 2016 Q4 | 141.9 Thousand USD | -52.18% |
| 2016 FY | 786.66 Thousand USD | 169.4% |
| 2016 Q2 | 276 Thousand USD | 283.33% |
| 2016 Q1 | 72 Thousand USD | -51.68% |
| 2016 Q3 | 296.76 Thousand USD | 7.52% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | 149 Thousand USD | 132.81% |
| 2015 Q3 | 64 Thousand USD | -18.99% |
| 2015 Q2 | 79 Thousand USD | 0.0% |
| 2015 FY | 292 Thousand USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | -100.0% |
| 2012 Q1 | 123.09 Thousand USD | 0.0% |
| 2012 Q3 | - USD | -100.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q2 | 188 Thousand USD | 52.73% |
| 2012 FY | 312 Thousand USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 28.037% |
| BrainsWay Ltd. | 31.78 Million USD | 72.698% |
| Cerus Corporation | 156.36 Million USD | 94.45% |
| Envoy Medical, Inc. | 316 Thousand USD | -2646.203% |
| electroCore, Inc. | 16.03 Million USD | 45.864% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -1247.516% |
| IceCure Medical Ltd | 3.22 Million USD | -168.752% |
| Inogen, Inc. | 315.66 Million USD | 97.251% |
| OrthoPediatrics Corp. | 148.73 Million USD | 94.165% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -257.414% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -2277.541% |
| MaxCyte, Inc. | 41.28 Million USD | 78.982% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -344.469% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -7735.807% |
| Orthofix Medical Inc. | 746.64 Million USD | 98.838% |
| PAVmed Inc | 2.45 Million USD | -253.915% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 61.464% |
| RxSight, Inc. | 89.07 Million USD | 90.258% |
| Sight Sciences, Inc. | 81.05 Million USD | 89.294% |
| SI-BONE, Inc. | 138.88 Million USD | 93.752% |
| TELA Bio, Inc. | 58.45 Million USD | 85.154% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 95.362% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 37.12% |
| Acutus Medical, Inc. | 7.16 Million USD | -21.133% |
| Talis Biomedical Corporation | 412 Thousand USD | -2006.311% |
| Spectral AI, Inc. | 18.05 Million USD | 51.938% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 12.388% |
| CVRx, Inc. | 39.29 Million USD | 77.916% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -795.834% |
| Bioventus Inc. | 512.34 Million USD | 98.306% |
| Venus Concept Inc. | 76.35 Million USD | 88.635% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 53.12% |
| LivaNova PLC | 1.15 Billion USD | 99.248% |
| 908 Devices Inc. | 50.22 Million USD | 82.723% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 98.201% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -11163.693% |
| NeuroPace, Inc. | 65.42 Million USD | 86.735% |
| LENSAR, Inc. | 42.16 Million USD | 79.418% |
| Apyx Medical Corporation | 52.34 Million USD | 83.423% |
| Cutera, Inc. | 212.36 Million USD | 95.914% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 73.985% |
| BioSig Technologies, Inc. | 18 Thousand USD | -48111.111% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 94.793% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 63.774% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.437% |
| Axonics, Inc. | 366.37 Million USD | 97.631% |
| Outset Medical, Inc. | 130.37 Million USD | 93.344% |
| IRIDEX Corporation | 51.86 Million USD | 83.269% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 93.628% |
| IRadimed Corporation | 65.56 Million USD | 86.764% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -637.925% |
| INVO Bioscience, Inc. | 3.02 Million USD | -187.296% |
| Telesis Bio, Inc. | 27.5 Million USD | 68.454% |
| Viemed Healthcare, Inc. | 183 Million USD | 95.258% |
| Varex Imaging Corporation | 811 Million USD | 98.93% |
| Quipt Home Medical Corp. | 221.74 Million USD | 96.086% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 87.364% |
| Dynatronics Corporation | 32.53 Million USD | 73.326% |
| Modular Medical, Inc. | - USD | -Infinity% |
| Semler Scientific, Inc. | 68.18 Million USD | 87.273% |
| InMode Ltd. | 492.04 Million USD | 98.236% |
| Bruker Corporation | 2.96 Billion USD | 99.707% |
| Cytosorbents Corporation | 36.34 Million USD | 76.126% |
| DexCom, Inc. | 3.62 Billion USD | 99.76% |
| Align Technology, Inc. | 3.86 Billion USD | 99.775% |
| Viveve Medical, Inc. | 6.42 Million USD | -35.045% |
| ZimVie Inc. | 457.43 Million USD | 98.103% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 95.504% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -7735.807% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 98.839% |
| Profound Medical Corp. | 7.33 Million USD | -18.374% |
| Insulet Corporation | 1.69 Billion USD | 99.489% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 93.117% |
| iCAD, Inc. | 17.31 Million USD | 49.89% |
| Nuwellis, Inc. | 8.86 Million USD | 2.098% |
| Biotricity, Inc. | 12.06 Million USD | 28.063% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 98.239% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -39.855% |
| PAVmed Inc. | 2.45 Million USD | -253.915% |
| BIOLASE, Inc. | 49.16 Million USD | 82.349% |
| Beyond Air, Inc. | 1.15 Million USD | -648.749% |
| FONAR Corporation | 102.88 Million USD | 91.565% |
| AxoGen, Inc. | 159.01 Million USD | 94.543% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 96.838% |
| Inari Medical, Inc. | 493.63 Million USD | 98.242% |
| UFP Technologies, Inc. | 400.07 Million USD | 97.831% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -46555.914% |
| Tenon Medical, Inc. | 2.92 Million USD | -196.38% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -27.392% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.729% |
| Sintx Technologies, Inc. | 2.62 Million USD | -230.339% |
| NanoVibronix, Inc. | 2.28 Million USD | -280.114% |
| Quanterix Corporation | 122.36 Million USD | 92.908% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 64.442% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 95.672% |
| TransMedics Group, Inc. | 241.62 Million USD | 96.408% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 37.361% |
| NeuroMetrix, Inc. | 5.9 Million USD | -47.049% |
| Hyperfine, Inc. | 11.03 Million USD | 21.338% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 94.745% |
| Biomerica, Inc. | 5.41 Million USD | -60.259% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 82.837% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 95.101% |